Kvalitativna procena pojedinaca u domu zdravlja porodične medicine: izbegavanje/odbijanje COVID-19 vakcinacije
Sažetak
Uvod. Izbegavanje/odbijanje vakcina je značajan javnozdravstveni
problem u COVID-19 pandemiji. Ovaj rad se
fokusira na izbegavanje/odbijanje COVID-19 vakcina u ambulanti
porodične medicine. Probaćemo da pronađemo i opišemo
faktore koji vode izbegavanju/odbijanju kako bi izgradili nove
strategije.
Metode. Ova studija je trajala od decembra 2021. do avgusta
2022. Osam pojedinaca je intervjuisano semi-strukturiranom
formom. Mesto održavanja studije je Turgut Reis, ambulanta
porodične medicine, Kajzeri u Turskoj. Tematska analiza je korišćena
za analizu kvalitativnih podataka.
Rezultati. Opredelili smo se za tri glavne i 16 podtema,
pregledajući beleške. Glavne teme su bili nivo znanja o COVID-
19, individualni i neindividualni faktori koji dovode do
izbegavanja/odbijanja COVID-19 vakcina. Realnost bolesti, zaštitne
mere, zabrinutost za sadržaj i proizvodni proces vakcina,
interakcija između hroničnih bolesti i COVID-19, pozitivni ili
negativni efekti religije i nacionalnog identiteta na vakcinaciju
su neke od podtema. Studija je pokazala da su zabrinutost u pogledu
sigurnosti vakcina, efikasnosti i proizvodnji, kao i individualne
želje, uticaj medija i obavezne zakonske forme nametnute
od strane zdrvastvenog menadžmenta bili najuticajniji faktori
za izbegavanje/odbijanje vakcina.
Zaključci. Iznenadna pojava COVID-19 dovela je do zakasnelog
odgovora od strane društva i zdravstvenih vlasti. Može
se takođe povezati i sa neverovanjem u postojanje bolesti, prihvatanjem
zaštitnih mera i poverenjem u opcije lečenja. Mada je
savremena tehnologija dostupna, relativno ograničen broj informacija
o efikasnosti vakcina i njihovom proizvodnom procesu
je došao do javnosti, te je i to moglo doprineti ovakvoj reakciji.
Reference
Budak F, Korkmaz Ş. COVID-19 Pandemi sürecine yönelik genel bir değerlendirme: Türkiye örneği. Sosyal Araştırmalarve Yönetim Dergisi 2020;1:62–79. doi: 10.35375/sayod.738657.
World Health Oraganization. COVID-19 vaccine tracker and landscape. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines Accessed January 13, 2021.
Fahrettin Koca Receives the First Coronavirus Vaccine. https://www.saglik.gov.tr/EN,78153/fahrettin-koca-receives-the-first-coronavirus-vaccine.html Accessed January 13, 2021.
Ozdarendeli A, Sezer Z, Pavel STI, Inal A, Yetiskin H, Kaplan B, et al. Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials. Vaccine 2023;41(2):380–90. doi: 10.1016/j.vaccine.2022.10.093.
COVID-19 Aşısı Ulusal Uygulama Stratejisi. https://covid19asi.saglik.gov.tr/TR-77706/covid-19-asisi-ulusal-uygulama-stratejisi.html Accessed January 13, 2021.
COVID-19 Vaccine Information Platform. https://www.gavi.org/covid19-vaccines?gad_source=1&gclid=EAIaIQobChMIkqbT0szvhwMVQoKDBx2ZiwztEAAYASAAEgLhzPD_BwE Accessed January 13, 2021.
Kalam MA, Davis TP Jr, Shano S, Uddin Md N, Islam Md A, Kanwagi R, et al. Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions. PLoS One 2021;23:16(8):e0256496. doi: 10.1371/journal.pone.0256496.
Bardosh K, de Figueiredo A, Gur-Arie R, Jamrozik E, Doidge J, Lemmens T, et al. The unintended consequences of COVID-19 vaccine policy: Why mandates, passports and restrictions may cause more harm than good. BMJ Glob Health 2022;7(5):e008684. doi: 10.1136/bmjgh-2022-008684
Fieselmann J, Annac K, Erdsiek F, Yilmaz-Aslan Y, Brzoska P. What are the reasons for refusing a COVID-19 vaccine? A qualitative analysis of social media in Germany. BMC Public Health 2022;22(1):846. doi: 10.1186/s12889-022-13265-y.
Wolfe RM, Sharp LK. Anti-vaccinationists past and present. BMJ 2002;325(7361):430–2. doi:10.1136/bmj.325.7361.430.
Latkin CA, Dayton L, Yi G, Konstantopoulos A, Boodram B. Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective. Soc Sci Med 2021;270:113684. doi:10.1016/j.socscimed.2021.113684.
Loraine B, Wick W, Gumbinger C. How to use and assess qualitative research methods. Neurological Research and practice 2020;2(1) (2020):3-10. doi: 10.1136/ebn.6.2.36.
Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant 2018;52(4):1893–907. doi:10.1007/s11135-017-0574-8.
Ayres L. Thematic Coding and Analysis. In: The SAGE Encyclopedia of Qualitative Research Methods. Given LM (ed). LA: SAGE Publications; 2008. p. 867–8.
Firmin MW. Themes. In: The SAGE Encyclopedia of Qualitative Research Methods. Given LM (ed). LA: SAGE Publications; 2008. p. 868–9.
Davies NG, Klepac P, Liu, Y. Prem K, Jit M; CMMID COVID-19 working group; Eggo RM. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med 2020;26(8):1205–11. doi:10.1038/s41591-020-0962-9.
World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions. https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions Accessed January 17, 2021.
Ali J, Ali Q, Hafeez M, Malik A. Clinical features, diagnosis and treatment of COVID-19. Biol Clin Sci Res J 2020;2020(1):31. doi:10.54112/bcsrj.v2020i1.31.
Evaluation of local and systemic side effects of Turkovac vaccine in adults. Kalayci BN, Karahan D. Turk J Med Sci. 2023 Aug;53(4):934-940. doi: 10.55730/1300-0144.5657. Epub 2023 Aug 18. PMID: 38031955
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial. Omma A, Batirel A, Aydin M, Yilmaz Karadag F, Erden A, Kucuksahin O, Armagan B, Güven SC, Karakas O, Gokdemir S, Altunal LN, Buber AA, Gemcioglu E, Zengin O, Inan O, Sahiner ES, Korukluoglu G, Sezer Z, Ozdarendeli A, Kara A, Ates I. Hum Vaccin Immunother. 2022 Nov 30;18(6):2122503. doi: 10.1080/21645515.2022.2122503. Epub 2022 Oct 31. PMID: 36315843
Dighriri IM, Alhusayni KM, Mobarki AY, Aljerary IS, Alqurashi KA, Aljuaid FA, et al. Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) side effects: A systematic review. Cureus 2022;14(3):e23526. doi:10.7759/cureus.23526.
Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, et al. Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA 2022;327(4):331– 40. doi:10.1001/jama.2021.24110.
Tunçer S, Tam MS. The COVID-19 Infodemic: Misinformation about health on social media in Istanbul. Türkiye İletişim Araştırmaları Dergisi 2022;(40):340–58. doi:10.17829/turcom.1050696.
El-Gilany AH. Infodemics of COVID-19 pandemic. Turk J Public Health 2020;18(Special issue):86–95.
Sarıoğlu EB, Turan E. COVID-19 ile İlgili Haberlerde Bilginin Yeniden Üretilmesi Sürecinin İnfodemik Açıdan Analizi. Electronic Turkish Studies 2020;15(6):819–37.doi: 10.7827/TurkishStudies.44109.
Sva prava zadržana (c) 2024 Ertan SiL, Mümtaz Mazıcıoğlu, Nilüfer Nahya, Ethem Bilgici
Ovaj rad je pod Creative Commons Autorstvo-Nekomercijalno-Deli pod istim uslovima 4.0 međunarodnom licencom.
Autori zadržavaju autorska prava nad objavljenim člancima, a izdavaču daju neekskluzivno pravo da članak objavi, da u slučaju daljeg korišćenja članka bude naveden kao njegov prvi izdavač, kao i da distribuira članak u svim oblicima i medijima.